1. Home
  2. MATH vs ZYXI Comparison

MATH vs ZYXI Comparison

Compare MATH & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATH
  • ZYXI
  • Stock Information
  • Founded
  • MATH 2015
  • ZYXI 1996
  • Country
  • MATH Hong Kong
  • ZYXI United States
  • Employees
  • MATH N/A
  • ZYXI N/A
  • Industry
  • MATH Finance/Investors Services
  • ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MATH Finance
  • ZYXI Health Care
  • Exchange
  • MATH Nasdaq
  • ZYXI Nasdaq
  • Market Cap
  • MATH 60.8M
  • ZYXI 66.5M
  • IPO Year
  • MATH N/A
  • ZYXI N/A
  • Fundamental
  • Price
  • MATH $1.60
  • ZYXI $2.18
  • Analyst Decision
  • MATH
  • ZYXI Buy
  • Analyst Count
  • MATH 0
  • ZYXI 3
  • Target Price
  • MATH N/A
  • ZYXI $10.25
  • AVG Volume (30 Days)
  • MATH 49.3K
  • ZYXI 262.3K
  • Earning Date
  • MATH 10-31-2024
  • ZYXI 04-29-2025
  • Dividend Yield
  • MATH N/A
  • ZYXI N/A
  • EPS Growth
  • MATH N/A
  • ZYXI N/A
  • EPS
  • MATH 0.17
  • ZYXI 0.09
  • Revenue
  • MATH $31,399,049.00
  • ZYXI $192,354,000.00
  • Revenue This Year
  • MATH N/A
  • ZYXI N/A
  • Revenue Next Year
  • MATH N/A
  • ZYXI $23.16
  • P/E Ratio
  • MATH $9.59
  • ZYXI $24.22
  • Revenue Growth
  • MATH 291.58
  • ZYXI 4.36
  • 52 Week Low
  • MATH $0.80
  • ZYXI $1.93
  • 52 Week High
  • MATH $2.78
  • ZYXI $12.19
  • Technical
  • Relative Strength Index (RSI)
  • MATH 45.92
  • ZYXI 26.14
  • Support Level
  • MATH $1.47
  • ZYXI $2.03
  • Resistance Level
  • MATH $1.70
  • ZYXI $2.24
  • Average True Range (ATR)
  • MATH 0.16
  • ZYXI 0.18
  • MACD
  • MATH -0.01
  • ZYXI 0.17
  • Stochastic Oscillator
  • MATH 47.84
  • ZYXI 38.46

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

About ZYXI Zynex Inc.

Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.

Share on Social Networks: